dn 1417 has been researched along with gamma-endorphin, des-tyr(1)- in 1 studies
| Studies (dn 1417) | Trials (dn 1417) | Recent Studies (post-2010) (dn 1417) | Studies (gamma-endorphin, des-tyr(1)-) | Trials (gamma-endorphin, des-tyr(1)-) | Recent Studies (post-2010) (gamma-endorphin, des-tyr(1)-) |
|---|---|---|---|---|---|
| 94 | 2 | 0 | 89 | 19 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inanaga, K; Mizuki, Y; Tanaka, M; Ushijima, I; Yamada, M | 1 |
1 trial(s) available for dn 1417 and gamma-endorphin, des-tyr(1)-
| Article | Year |
|---|---|
A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Clinical Trials as Topic; Electroencephalography; Endorphins; Female; Humans; Male; Middle Aged; Peptide Fragments; Psychiatric Status Rating Scales; Schizophrenia; Thyrotropin-Releasing Hormone | 1986 |